Searchable abstracts of presentations at key conferences in endocrinology

ea0096p11 | Section | UKINETS2023

How gallstones can affect the course of PRRT

Coldham Mr. Chris , Smith Mrs Stacey , Shah Dr. Tahir

Introduction/Background: Somatostatin analogue injections are a mainstay for the treatment of Neuroendocrine Tumours. Gallstones are a known adverse effect of this treatment. PRRT can bring extra complications for patients having an episode of cholecystitis, biliary colic, cholangitis or pancreatitis.Aims: To examine a cohort of patients undergoing PRRT, looking for the incidence of gallstones and how many patients suffe...

ea0096p10 | Section | UKINETS2023

A prrt patient experience survey – what really matters to patients?

Coldham Mr. Chris , Butler Mrs Vicky , Brown Mrs Emily , Smith Mrs Stacey , Shah Dr. Tahir

Introduction/Background: PRRT is a high cost treatment for progressing Neuroendocrine tumours. Patients and healthcare providers invest heavily in the treatment journey that lasts a number of months.Aims: To assess the level of patient satisfaction with the PRRT service, to indicate areas for possible improvement and good practice and serve as a baseline for future assessments.Material and ...